Switzerland / 3 Questions for Federal Office of Public Health DG Anne Lévy
As part of the Federal Department of Home Affairs, the Federal Office of Public Health (FOPH) is responsible for…
Novartis USA
Last updated: 05.11.2015
Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, central nervous system, cancer, ophthalmics, organ transplantation and respiratory areas.
Contact details
5200 Blue Lagoon Dr # 690
Miami, FL 33126
United States
+1 786-388-2102
Related
Mexico-US Vaccine Tourism / Closed Borders, Fear of Fakes & Plane Crashes
While Mexico struggles with its COVID-19 vaccination campaign, residents of the country’s northern states have…
Thomas Bohn – Executive Director, Greater Geneva Bern area (GGBa), Switzerland
Thomas Bohn outlines how the life sciences industry in Western Switzerland has continued to perform well despite…
Carl Firth – CEO, ASLAN Pharmaceuticals
ASLAN Pharmaceuticals is a clinical-stage immunology-focused biopharmaceutical company. CEO Dr Carl Firth reveals…
USA / Rare Disease Strategies in a Booming Market
Rare disease – defined in the US as a disease with a maximum patient population of 200,000 – is perhaps the…
Hisham Bin Saad Al-Jadhey – CEO, Saudi Food and Drug Authority (SFDA)
Speaking exclusively to PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority…
Shiva Kannan – Vice President, Commercial Chief Information Officer, GE…
Shiva Kannan, VP and Chief Information Officer for GE Healthcare in over 120 countries, discusses the company’s…
Annalise Eggimann – CEO, Innosuisse
Innosuisse CEO Annalise Eggimann presents the organisation’s renewed mandate as the main Swiss innovation…
Antonella Santuccione Chadha – CEO pro-bono, Women’s Brain Project…
Antonella Santuccione Chadha*, Head of Stakeholder Engagement for Alzheimer’s disease at Biogen and co-founder…
Switzerland / Ichnos CEO on Glenmark Legacy, Biotech Transformation & CAR-T Complementarity
After an illustrious career in oncology R&D, contributing greatly to the development of cutting-edge cancer…
Jan Tangermann – Country Head, Sandoz Switzerland
Sandoz Switzerland’s Jan Tangermann highlights the importance of the Swiss affiliate to the global group and how…
Susan M. Gasser – Director Emeritus & Group Leader, Friedrich…
Professor Susan M. Gasser, now director and group leader emeritus of the Friedrich Miescher Institute for…
China / Hitgen Aims to Strengthen its “Innovation Foundation” with UK & US Partnerships
PharmaBoardroom had the pleasure of interviewing HitGen chairman & CEO Dr Jin LI in July regarding the…
Korea / Samsung Bioepis Goes Down Under; Blockchain-Based Vaccine Certificates; The First Korean Blockbuster?
The latest news from Korean pharma, including how Korea can put the infrastructure in place to develop a homegrown…
Europe / Vaccine Wars: What the EU/AstraZeneca Row Shows Us About Pharma Cross-Border Litigation
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and litigation examines the origins and…
USA / 5 Rare Disease Start-Ups to Watch
Following on from our profile on five of the most promising clinical-stage biotech companies developing orphan…
The COVID-19 Vaccine Rush / Nationalism, Access & IP Issues
The global rush to secure access to COVID-19 vaccines has led to accusations that richer countries are hoarding…
Pharma Logistics Under COVID / Partnerships, Digitalisation & New Customer Service Models
The vital importance of robust supply chains and distribution networks has been foregrounded over the past year as…
Switzerland / The Quest for Alternatives to Animal Testing
Animal testing for medicinal purposes is back under the spotlight in Switzerland after a petition against the…
Switzerland / What Three Pharma Leaders Want to Share
PharmaBoardroom highlights three of the most enterprising and dynamic pharma affiliate country managers working in…
Global / Innovative Pharma Doubles Down on IP with New Pact
On World Intellectual Property (IP) Day 2021, the innovative biopharmaceutical industry came together to launch a…
China / HiFiBiO CEO on the Keys to Global Biotech Success
HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T:…
The bright future of mRNA technology – InConversation Podcast #Episode1:…
Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer…
Bertrand Ducrey – CEO, Debiopharm
In a wide-ranging interview CEO Bertrand Ducrey introduces Debiopharm’s unique business focus on drug…
Stefan Hendriks – Global Head Cell & Gene, Novartis Oncology
Stefan Hendriks, Global Head of Novartis Oncology’s Cell & Gene division outlines the company’s progression…
Dennis Hens – CEO, Bulbitech
Dennis Hens, the Dutch CEO of Norwegian neuro-opthalmology device player Bulbitech, outlines the company’s…
Gideon Ho – Co-Founder & CEO, HistoIndex
Dr Gideon Ho, co-founder and CEO of HistoIndex, shares the story of the company’s establishment in 2010, their…
Ana Hidalgo-Simon – Head of Advanced Therapies, European Medicines Agency
The EMA’s Head of Advanced Therapies Dr Ana Hidalgo-Simon outlines Europe’s evolving regulatory framework for…
Europe / After Brexit: Focus on the New Pharmaceutical Strategy for Europe
Writing in the February edition of DIA’s Global Forum magazine, Thomas Kühler of Sanofi R&D looks at the…
Switzerland / ISREC’s Susan Gasser: A “Hard-Nosed” Approach to Research Quality & Excellence
After 15 years as director at the Friedrich Miescher Institute for Biomedical Research (FMI) (2004-2019) and even…
LatAm / COVAX Rollout in Colombia; União Quimica to Manufacture Sputnik Vaccine in Brazil; Mexico Cannabis Update
The latest LatAm pharma news, including COVID-19 vaccine rollouts in Colombia, Brazil, and Mexico as well as legal…
LatAm & Caribbean / Importance of Reliance to Support Strengthening Regulatory Systems
Writing in the April edition of DIA’s Global Forum magazine, Maria Cristina Mota Pina of Abbvie on behalf of…
Asia-Pacific / World’s Largest Trade Deal’s Pharma Impact Too Early to Tell
On 15 November 2020, the world’s largest trade deal in terms of GDP – the Regional Comprehensive Economic…
Nicolas Fischer – CEO, Light Chain Bioscience
Dr Nicolas Fischer introduces Light Chain Bioscience, a Swiss biotech company focusing on the discovery and…
Talent / Pharma Country Managers: The COVID Generation
While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive,…
Daniel Malarek – General Manager, Roche Diagnostics Norway
Roche Diagnostics Norway’s Daniel Malarek discusses the resurgence of diagnostics in the wake of the COVID-19…
Lance Little – Managing Director (Asia Pacific), Roche Diagnostics; Board…
Lance Little, managing director for Roche Diagnostics in Asia Pacific and board member of the Asia Pacific Medical…
Haijun Dong – CEO, BioDuro-Sundia
Dr Haijun Dong, recently appointed CEO of BioDuro-Sundia, shares his priorities for the newly merged entity, one of…
Jacques Marbehant – Senior Vice President, Head of Global Manufacturing,…
Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad…
Genald Senior – General Manager, Leterago
Genald Senior, general manager for Leterago, the leading pharma distributor in the Dominican Republic, discusses…
Vincent Gruntz – General Manager Oncology, Novartis Pharma Switzerland
Vincent Gruntz looks at the market dynamics for oncology in Switzerland, where an increasingly cost-conscious…
San Diego / What it Takes to be a Successful Life Science Innovation Centre
Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park highlights key takeaways from the BIOJapan 2020…
Russia / Biocad Ramps up Sputnik V Manufacturing; Unlicensed Remdesivir Generics; Chinese Vaccine Rejection
The latest Russia Pharma News, including Biocad’s ramping up of Sputnik V COVID-19 vaccine manufacturing,…
Andrea Emilio Rizzoli – Director, Dalle Molle Institute for Artificial…
Andrea Emilio Rizzoli of the Dalle Molle Institute for Artificial Intelligence, among the top 10 in the world in…
MEA / Iran looks to Cuba for COVID-19 Vaccine; Israel Leads Vaccination Race; Dubai-Hyderabad Vaccine Corridor
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region, including the fallout from…
Switzerland / MSD AVP on Recent Zurich R&D Investment
In February 2020, US giant MSD announced the launch of a new site in Zurich specialising in R&D, data…
LatAm / Accelerated Regulatory Assessment of Innovative Medicines
Writing in the March edition of DIA’s Global Forum magazine, EMD Serono’s Ana Padua outlines the findings…
UK / New Post-Brexit Regulatory Alliance with Australia, Canada, Singapore & Switzerland
When the European Medicines Agency (EMA) relocated from London to Amsterdam after the UK announced its decision to…
Ipsen / CEO David Loew: Pharma Has to Play “A Wider Role” in Shaping Healthcare
Ipsen CEO David Loew took aim at the lip service often paid to the notion of ‘patient-centricity’ in pharma in…
Thomas D. Szucs, European Center of Pharmaceutical Medicine at the University of…
Genomic medicine expert Professor Thomas D. Szucs explains what ignited his interest in the field and how payers…
Anil Okay – General Manager, Adalvo & Chief Commercial Officer,…
CCO Anil Okay introduces how Alvotech’s focus on biosimilars, comprehensive platform, differentiated portfolio…
Mexico / On the Brink of Becoming the World’s Largest Legal Cannabis Market
Last Wednesday, the lower chamber of the Mexican Congress approved a bill that would legalise recreational…
Italy / Mandatory COVID-19 Vaccines for Healthcare Workers; Chiesi & Angelini’s AI Investments; Sputnik V Manufacturing
The latest Italy Pharma News, including the government’s decision to make COVID-19 vaccines mandatory for all…
Japan / Taiho Pharmaceutical: An Oral Chemotherapy Pioneer
Japanese pharma companies are already far lower-profile than their occidental counterparts but an even lesser-known…
Barış Erdoğan – CEO, Clinerion
Clinerion, a leader in real-world data solutions, is helping bring medical data informatics to the life sciences…
M&A / Jazz’s $7.2 Billion GW Pharma Deal: A Major Boost for Cannabinoid Research
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that day, the British biopharmaceutical…
Italy / Menarini CEO on Averting Future Health Crises; Alfasigma Hackathon; January COVID Vaccines
A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with…
Tim Philippi – Executive Director, Singaporean-German Chamber of Industry…
The SGC’s Dr Tim Philippi introduces the sizeable Singaporean-German trading relationship and the importance…
JP Morgan 2021 / A Course Correction for Future Meetings
David H. Crean summarizes the recent 39th annual J.P. Morgan Healthcare Conference 2021 that was held in a virtual…
USA / Is Its Innovation Leadership Position At-Risk?
David H. Crean, managing director for Objective Capital Partners, provides insights on US innovation and long term…
Latvia / Striving to Catch Up to its Neighbours on Innovation Access
Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals…
APAC / Aligning Combination Product Regulations: A Distant Dream?
Writing in the April edition of DIA’s Global Forum magazine, Dhiraj Behl, Janine Jamieson, and Harikesh Kalonia…
Niklas Hedberg – Chair of the Executive Board, EUnetHTA; Chief Pharmacist,…
Niklas Hedberg outlines the role of EUnetHTA as both a network and project built up of national HTAs in Europe, the…
Global / Top 5 CDMOs
As the global pharmaceutical industry continues to grow, so have opportunities for service providers. Over the last…
USA / Takeda’s Ramona Sequeira Talks “Culture as Strategy”
After five years with Takeda heading up the Japan-headquartered pharma company’s US business, following the…
APAC / Diagnostics in the Post-COVID Era
COVID-19 has pushed diagnostics to the forefront of healthcare conversations across the world. Here, three leading…
Praful Chakkarwar – Country Manager, Novo Nordisk Pharma Singapore
Novo Nordisk Singapore’s Praful Chakkarwar explains how he leverages his experience in a range of geographies…
India / 200% Pharma Sector Budget Boost; 3x Industry Growth in Next Decade; Pfizer Vaccine Rebuffed
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
Vaccines / Manufacturing & Supply Chain Complexity
Pharma industry insiders view vaccines as one of the most challenging products to manufacture, fundamentally due to…
Alaa Gamal – Senior Executive & Regional Pharma Expert, MENA
When it comes to knowledge of the Middle East and Africa region’s pharmaceutical industry, few executives have…
Turkey / Koçak Farma & The Push for Homegrown COVID-19 Vaccines
As the international community continues its quest to vaccinate the global population against COVID-19, shortages…
Andrew Frye – SVP & President, APAC, Baxter
Andrew Frye of medtech giant Baxter outlines his management strategy for the diverse APAC region, how growth was…
Population Health / Deloitte Global Healthcare Leader on COVID-19 Vaccine Challenges
Scientists have come together in an unparalleled worldwide collaboration and sharing of data to advance a COVID-19…
Asia-Pacific / HSA: A Regulatory Gold Standard for the Region
As the most important pharma hub in its region, and one of the most important globally, many companies look to…
Saudi Arabia / 5 Things to Know
A rundown of five things to know about the USD 8.2 billion Saudi pharma market, including the impact of ‘Vision…
GSK / 6 Key Takeaways from Vaccines Head Roger Connor at FT Conference
During the FT Global Pharmaceutical and Biotechnology Conference last week, GSK global vaccines president Roger…
Personalised Medicine / Miro Venturi - CEO, Sintetica
Dr Miro Venturi of Swiss injectable anaesthetics and analgesics specialist Sintetica outlines his career journey,…
Switzerland / Building a Health Data Ecosystem
Although Switzerland is ahead of many of its competitors in Europe on levels of healthcare innovation, one…
Southeast Asia / Singapore Pharma Production Surge; Indonesian Self-Sufficiency; Philippines Sputnik Vaccine Manufacturing
The latest from Southeast Asian pharma, including soaring output in Singapore, tax breaks for research in…
Joe Lewis – Managing Director, Life Sciences Supply Chain Practice,…
Joe Lewis outlines the key concerns of Deloitte’s pharma clients around manufacturing and supply chain operations…
LatAm / Vaccination Challenges; Colombian COVID Variant; Pfizer’s Peru Problem
The latest news from pharma and healthcare in Latin America, including funding and logistics challenges in national…
Mario Klesse – Country Director, Janssen Norway
Janssen Norway’s Mario Klesse shares his first impressions of the Norwegian pharma market, his strategic…
Germany / Highest Honours for BioNTech Founders; Bayer’s Growth Predictions; Merck Making Further French Investments
A roundup of some of the most important recent news from German pharma, including state honours for the founders of…
Maria T Millan – President & CEO, California Institute for…
Dr Maria T. Millan, president and CEO of the California Institute for Regenerative Medicine (CIRM), shares the…
China / Public Insurance Coverage for Rare Disease Patients: Beijing & Shanghai Surprisingly Low in New City Ranking
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare Disorders (CORD), outlines the…
Ching Kiat LIM – Managing Director, Airhub Development, Changi Airport…
Changi Airport Group’s Ching Kiat LIM reflects on a challenging 2020 for the airline industry, Changi’s…
Lorenzo Ambrosini – CEO, Agire Foundation, Switzerland
Lorenzo Ambrosini of the Agire Foundation introduces the major new innovation projects underway in the…
France / ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal; AntiVax Struggles; Servier’s Neurology Push
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19…
Canada / The Evolution of Medical Cannabis Legislation
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical cannabis industry in Canada, its…
RWE / Unlocking the Full Potential of Cell & Gene
Emerging cell and gene therapies herald immense clinical value for patients, society, and healthcare systems:…
Cell & Gene Therapy / Embryonic Gene Editing: How Far is Too Far to Find a Treatment for Your Child?
Rare disease patient advocate Monica Weldon outlines some of the ethical conundrums around embryonic gene editing.…
Bandar Reda – CEO & Secretary General, Arab-British Chamber of…
Bandar Reda outlines the evolution of the trading relationship between the UK and the Arab world, the role of the…
Dan Leonard – President & CEO, Association for Accessible Medicines…
Dan Leonard, president and CEO of the Association for Accessible Medicines (AAM) since August 2020, outlines his…
LatAm / Megalabs: Playing Among Giants
The Top 15 pharmaceutical companies in the Central America and Caribbean (CENCA) market list is dominated by…
Liang Schweizer – CEO & CSO, HiFiBiO Therapeutics
Dr Liang Schweizer introduces immunotherapy-focused biotech HiFiBiO Therapeutics, the main advantages of the…
Cell & Gene Therapy / Funding the Boom
The ascent of cell and gene therapies (CGT) is commonly regarded as one of the momentous turning points in the…
Ümit Dereli – Secretary General, AIFD, Turkey
Ümit Dereli is secretary general of the Turkish Association of Research-Based Pharmaceutical Companies (AIFD),…
MENA / Egypt Opens 'Pharma City'; Koçak’s COVID Vaccine Enters Phase I; Abu Dhabi Strengthens Hub Status
The latest Middle East and North Africa (MENA) pharma, including Egypt’s opening of the largest “pharmaceutical…
China / Yangtze River Pharmaceutical Group (YRPG) in Profile
One of the largest domestic pharma companies in China (ranking number one from 2014 to 2019), Yangtze River…
Thomas F. Schmidt – Managing Director, Roche Pharma Switzerland
Thomas F. Schmidt, country manager of Roche Pharma in its home market of Switzerland discusses adjusting to his…
Singapore / Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long been one of Asia’s leading…
Katharina Gasser – Managing Director, Biogen Switzerland
Biogen Switzerland’s Dr med Katharina Gasser outlines how her affiliate navigated the COVID-19 pandemic from an…
Talent / Biogen's Swiss Head on Benefits of Diverse Experience & Building an Entrepreneurial Team
A trained physician with several years of practice under her belt, Katharina Gasser then moved into clinical…
Vaccines / An Expanded R&D Playbook
The story of how British doctor Edward Jenner serendipitously discovered a way to inoculate people against smallpox…
Cell & Gene Therapy / Reconsidering Manufacturing
Advances in cell and gene therapies (CGT) are credited with thoroughly transforming medicinal science and creating…
Europe / Can The Beating Cancer Plan Make it an Innovation Leader?
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
Rubens Hannun – President, Arab Brazilian Chamber of Commerce, Saudi…
Rubens Hannun, president of the Arab Brazilian Chamber of Commerce, discusses the commercial relationship between…
Pay-For-Performance / Novartis Oncology President: “If We Offer It, Healthcare Systems Should Use It!”
During the FT Global Pharmaceutical and Biotechnology Conference earlier this month, three industry leaders spoke…
Giorgio Calderari – Chairman, Farma Industria Ticino (FIT), Switzerland
Giorgio Calderari, the chairman of Farma Industria Ticino, the association of chemical and pharmaceutical…
USA / U-Turn as Biden Pledges Support for Waiver on COVID-19 Vaccine IP
In a shock move, Joe Biden’s administration looks set to support a waiver on intellectual property (IP)…
USA / Novartis Oncology: Leaning into Change
With a series of reorganization initiatives, new leaders at the helm and exciting acquisitions, Novartis Oncology…
Alejandro Mora – Country Manager Central America & Caribbean, Ferrer
Alejandro Mora, Ferrer’s country manager for Central America & Caribbean, discusses the complexity of the…
China / 5 Top Trends in Healthcare & Biopharma in 2020
2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being…
Switzerland / A Sea Change in the Biotech Start-up Ecosystem?
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine Venture Partners, a venture capital (VC)…
Pius Zängerle – Director, curafutura, Switzerland
Pius Zängerle of curafutura, one of the two largest Swiss health insurers’ associations, explains the unique…
Global / Top 10 PharmaBoardroom Interviews of 2020
2020 was a challenging year globally, but one in which the importance of the healthcare and life sciences sector…
Brazil / Pharma Market Outperforming LatAm, Vaccine Developments, Bolsonaro’s Political Standing
The Brazilian pharma market outperformed the Latin American average in Q1 of 2020 with a growth of 8.2 percent in…
APAC / Prestige & HH&L IPO News; Cold Chain Vaccine Challenges; Moderna Looks to CMOs
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for Prestige Biopharma and HH&L…
Spain / Grifols looks to Egypt; New Leadership Generation at Almirall; Ferrer’s EIB Loan; Esteve’s European Expansion
The latest from Spanish pharma, including the wide swathe of COVID-19 syringes, vaccines, masks, and tests being…
Marc-Olivier Geinoz – CEO, Dipharma SA
Dipharma SA is a Swiss specialty pharmaceutical company, developing improved generics medicines for rare metabolic…
Ai Li Siow – Managing Director, Siemens Healthineers Singapore
Siemens Healthineers Singapore’s Ai Li Siow outlines how her affiliate has pivoted in order to continue to…
MEA / Pfizer’s Saudi Transformation; Urgent Call for Arab Import Reform; Hikma & Tabuk Deals
The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi…
USA / Securing the Conditions to Secure Our Meds
The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar have on US healthcare today and…
Choong May Ling, Mimi – CEO, Health Sciences Authority (HSA), Singapore
Dr Choong May Ling, Mimi, CEO of Singapore’s Health Sciences Authority (HSA), one of the leading regulatory…
China / Antitrust Threat to Pharma; June BioNTech Vaccine Approval; EpimAb IPO; CanSino Inhaled Vaccine Trials
The latest China pharma news, including the upcoming first domestic approval for a foreign COVID-19 vaccine in…
China / New Drug Approvals 2020
Writing in the February edition of DIA’s Global Forum magazine, Xu Wang of Novo Nordisk Pharma China and Xiaoxi…
Larry St Onge – President, Life Sciences and Healthcare, DHL
DHL’s Larry St Onge outlines how the logistics giant adapted to the COVID-19 pandemic in 2020, the unprecedented…
Global / 10 Key Insights from PharmaBoardroom Contributors in 2020
Although the COVID-19 pandemic and the subsequent rush to develop diagnostics, therapeutics, and vaccines dominated…
Ellen Cathrine Andersen – CEO, EpiGuard
CEO Ellen Cathrine Andersen introduces Norwegian firm Epiguard’s ‘Epishuttle’ technology for transporting…
Christian Probst – General Manager, GSK Norway
Christian Probst gives an overview of GSK Norway’s broad portfolio, market access hurdles, and the importance of…
Global / 2020's Top 7 Biotech IPOs In Profile
Following the recent news of Remegen’s massive USD 515 million IPO in November 2020, we bring you profiles of…
The Long Read / Norway: Unlocking Potential
Equality has long been a deeply held ideal in Norway, where the concept of allemannsretten – the legal right to…
Nawal Roy – Founder & CEO, Holmusk
Nawal Roy of global digital health platform Holmusk which aims to establish data as a core utility to the treatment…
Spain / Market Growth; Esteve’s US Expansion; PTS Acquisition
The latest from Spanish pharma, including the acquisition of PTS by a private equity group for its nanoparticle…
COVID-19 Vaccines / Valneva: A Success Story for France?
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
Italy / Stevanato’s $5 bn valuation; Zolgensma Approval; Sputnik V Manufacturing
The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine…
Alessandro Riva – CEO, Ichnos Sciences
Alessandro Riva, MD joined biotech Ichnos Sciences as its founding CEO in 2019, leaving behind a storied career in…
Germany / STADA’s Bold Bets on M&A
After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness…
Biosimilars / Alvotech's Four Traits for Success
Alvotech – the biosimilars arm of Icelandic-headquartered generics player Alvogen – is positioning itself for…
Ashish D Pal – Managing Director, MSD Singapore, Malaysia & Brunei…
MSD’s Ashish Pal describes how he led the Singapore, Malaysia, and Brunei cluster through a challenging 2020; the…
Samir Khalil – Executive Director, PhRMA Middle East & Africa
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents many of the world’s leading…
APAC / Medtech's Post-COVID Paradigm
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech market and, with a CAGR of nine…
Jürg Utzinger – Director, Swiss Tropical & Public Health Institute…
Prof Dr Jürg Utzinger of the Swiss Tropical and Public Health Institute (Swiss TPH) outlines the organisation’s…
Filip Standaert – Managing Director Nordics, Johnson & Johnson
Filip Standaert outlines the significance of the Nordic cluster to J&J’s medical device operations in Europe,…
Kirsti Nyhus – Market Access & External Affairs Director Scandinavia…
AbbVie Norway’s Kirsti Nyhus discusses access challenges in the Norwegian market for innovative drugs, the…
Mexico / US Vaccine Tourism; CanSino Stepping Up; AMLO Calls for UN Intervention
The latest from Mexico’s fight against COVID-19, including news of vaccine tourism into the US, how China’s…
Harjit Gill – CEO, APACMed
In an exclusive and wide-ranging interview, Harjit Gill outlines the work of pan-Asia-Pacific medtech association…
Europe / Will New Pharmaceutical Strategy Prove to be a Game-Changer?
On 25 November 2020, the European Commission adopted a Pharmaceutical Strategy for Europe with the stated aim of…
Leonora Lim – VP, Life Sciences & Healthcare, Customer Solutions…
Leonora Lim, DHL’s Asia-Pacific VP for Life Sciences and Healthcare, Customer Solutions & Innovation, dives…
HIV / Janssen’s Johan Van Hoof on Search for The Vaccine ‘Holy Grail’
With several COVID-19 vaccines gaining regulatory approval across the world in record time, a spotlight has been…
Global / PharmaBoardroom Most Read Interviews of 2020
The top 10 most-read interviews on PharmaBoardroom in 2020 represents the broad geographic scope we have had in the…
Europe / Cross-Country Collaborations: The Future of Pricing & Access Negotiations?
Merck VP for Global Market Access & Pricing Strategic Planning Marco Rauland examines the trend of…
Lucas Chan – Scientific Founder & CSO, CellVec
Lucas Chan, Scientific Founder and CSO of CellVec, a Singapore-based CDMO that specializes in the development and…
Norway / Neuroscience: Nobel Prizes & Enduring Focus
Norway has long held a strong international position in neuroscience and is home to Professors May-Britt and Edvard…
Vaccines / Top 4 Global Companies
Four companies (GSK, Pfizer, Sanofi, and MSD) together occupy over 80 percent of the global market for vaccines.…
Michael Sidler – Co-Founding Partner, Redalpine Venture Partners,…
Redalpine Venture Partners’ Dr Michael Sidler highlights some of the key trends in the European biotech VC…
USA / The Long Read: Innovation, Access & Affordability
A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly…
Europe / The Need for a Sustainable Pharma Manufacturing System
On 25 November, the European Commission adopted a new strategy meant to, among others, allow Europe to cover its…
Johan Van Hoof – Global Therapeutic Area Head of Vaccines, Janssen
Dr Johan Van Hoof, global therapeutic area head of vaccines for Janssen, shares his extensive career experience in…
USA / NORD Chief Strategy Officer on Health Equity's Vital Importance for Rare Disease Patients
With Rare Disease Day coming up on February 28th, one of the leading organizations dedicated to serving affected…
Probir Das – Chair and Managing Director, Terumo Asia Holding
Japanese medtech player Terumo’s APAC lead Probir Das outlines the company’s 100-year commitment to innovation,…
APAC / The Challenges of Regulatory Convergence in Medtech
Regulatory harmonisation for medical devices between countries in Asia-Pacific has long been a challenging issue,…
Europe / EUnetHTA's Uncertain Future & the Evolution of European HTA
The journey of EUnetHTA began back in 2004, when the European Commission and Council of Minsters requested the…
M&A / Bayer Strategy Head: Big Pharma “Needs to Up its Game”
During the FT Global Pharmaceutical and Biotechnology Conference earlier this week, four Big Pharma and biotech…
Vaccines / IFPMA's Thomas Cueni on why "#TeamVaccines is all of us"
Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) highlights…
Thomas A. Tóth von Kiskér – CEO & Board Member, Tillotts Pharma AG
Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a Switzerland-based specialty pharma player…
Khalid Saleh – Managing Director, Mera Pharma
Mera Pharma’s Khalid Saleh introduces the Swiss-headquartered but MENA-focused company, how it plans to expand…
USA / What to Expect if Janet Woodcock Becomes Permanent FDA Head
Hours after President Biden was inaugurated on Tuesday 19th January 2021, Dr Janet Woodcock was named as acting…
Remo Gujer – General Manager, BMS Switzerland & Austria
Dr Remo Gujer gives an overview of the BMS footprint in Switzerland and Austria, the ongoing integration of legacy…
China / Boehringer Ingelheim's Stroke Rehab Centre Success & Continuing China Push
In March 2018, German pharma player Boehringer Ingelheim (BI)‘s Consanas Rehabilitation and the Shanghai…
Sweden / Taking the Lead in Precision Medicine?
Anders Blanck of Lif, the trade association for the research-based Swedish pharmaceutical industry, outlines the…
Vaccines / Market Model Innovation
While perhaps not as lucrative or – prior to COVID-19 – as attention-grabbing – as other areas of the…
Nicolaus Kröger – President, European Society for Blood and Marrow…
Professor Nicolaus Kröger, president of the European Society for Blood and Marrow Transplantation (EBMT)…
Switzerland / Michael Altorfer - CEO, Swiss Biotech Association
Michael Altorfer, CEO of the Swiss Biotech Association, a membership organisation representing the interests of the…
China / Sinopharm Vaccine Approval; Online Healthcare Boom; 51% Drug Price Cuts
The latest from Chinese pharma, including domestic regulatory approval for Sinopharm’s COVID-19 vaccine, how…
M&A / Viatris: Cost-Cutting Needed at New Generics Behemoth
In November 2020, after months of delay caused by COVID-19 disruptions and a US antitrust roadblock, Mylan and…
Jean-Paul Clozel – CEO, Idorsia
In an exclusive interview, Jean-Paul Clozel explains Idorsia’s unique value proposition as a biotech focused…
Sissel Lønning Andresen – Country Manager & Internal Medicines Lead,…
Sissel Lønning Andresen explains how Pfizer Norway has been a pioneer of digital communication channels for years,…
South Africa / Aspen Inks Deal to Manufacture J&J’s COVID-19 Vaccine
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed…
Daniel Fung – CEO, Institute of Mental Health, Singapore
Singapore’s Institute of Mental Health offers a comprehensive range of psychiatric, rehabilitative, and…
Norway / Photocure: Swimming in the “Blue Ocean” of Oncology Drug-Device Combinations
Photodynamic therapy (PDT) firm Photocure is probably Norway’s most significant recent international healthcare…
Novavax / From No-Hoper to COVID-19 Vaccine Saviour?
From almost being de-listed by the NASDAQ stock index in 2018 due to poor financial performance, US vaccine firm…
China / National Reimbursement Drug List (NRDL) 2020: What Reward for Innovation?
Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact…
Ans Heirman – AVP Managing Director, MSD Switzerland
Switzerland is a crucial country for MSD’s global network, employing over 1000 people in local, regional, and…
Global / Ebola Vaccine Lessons for COVID-19 & The Future of Global Health
Epidemiologist John-Arne Røttingen has had a long and distinguished career in both academia and industry,…
Canada / Federal Consultations on a National Strategy for Rare Disease Drugs
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health…
Brian O’Callaghan – CEO, ObsEva
Biotech veteran Brian O’Callaghan introduces ObsEva – a Swiss-based firm focused on women’s health –, his…
Jon Helsdingen – General Manager, AbbVie Switzerland
AbbVie Switzerland’s Jon Helsdingen outlines how he has led the Swiss affiliate through a full scale office…
Sizhen Wang – CEO & Co-Founder, Genetron Health
Genetron Health is a publicly-traded China-based precision oncology company, covering the “full-cycle” of…
The Long Read / Switzerland: Staying the Course
This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive…
USA / 2 Things the Biden Administration can do Now to Lower Costs at the Pharmacy
PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can help lower healthcare costs and why…
China / Pharma Share Price Hit; Pfizer-LianBio Linkup; Novo’s New Chatbot
The latest from Chinese pharma, including a drop in share prices for Chinese vaccine firms in the wake of…
Eric ten Kate – Vice President, Global Life Science, Agility
Eric ten Kate, VP for Global Life Science at logistics and distribution firm Agility, highlights how the company…
Alex Pombo – Co-Founder & CEO, Nerum Pharmaceuticals
Nerum Pharmaceuticals, a Switzerland-based start-up, is supplying high-grade cannabis products to nine countries…
Vincent Ruland – Country Division Head, Bayer Pharmaceuticals Malaysia,…
Bayer’s Dr Vincent Ruland highlights his career trajectory from medical doctor to pharma country manager; the…
Russia / $7.4 bln for Healthcare Modernisation; Generics Push; Sputnik Vaccine Successes
The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025,…
Mervyn Lim – Vice President, ResMed Asia
Mervyn Lim, Vice President, ResMed Asia, shares the company’s journey through COVID-19 in the region, how the…
Mental Health / New Global Initiative Aiming to Solve $2 Trillion Problem
COVID-19 has drawn global attention to the sorry state of funding and R&D investment in vaccine development and…
USA / The Value Proposition of Generics & Biosimilars
AAM President Dan Leonard highlights the findings of the association’s most recent report and re-states the value…
China / AstraZeneca/Junshi anti-PD-1 Tie-Up; New UK Biologics Plan for Pharmaron; Clover’s $230 Million Investment Boost
The latest from Chinese pharma, including a new deal between AstraZeneca and Junshi Biosciences; Innoforce and…
Global / PharmaBoardroom's Top Women Leaders 2020
While great strides in gender diversity has been made within healthcare boardrooms and leadership teams globally,…
UK / Fastest Growing Private Pharmacos; GSK Shake-Up; Brexit Uncertainties; COVID-19 Reinfection Trial
The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma…
EMEA / Janssen SVP Cyril Titeux Talks Access, Talent, Data & Vaccines
Janssen’s Cyril Titeux highlights the commonalities and challenges within his 31-country portfolio, his hopes and…
Brazil / Country's Largest Private Pharma Company Under Threat
Founded in 1950, EMS is one of the top two domestic pharma companies in Brazil. As a key player in the largest and…
Cell & Gene Therapy / CRISPR-Cas9 Nobel Prize Pioneers in Profile
On 7 October 2020, the 2020 Nobel Prize in Chemistry was jointly awarded to Emmanuelle Charpentier and Jennifer A.…
Sanjay Prabhakaran – President, Asia Pacific, Hologic
Medtech industry veteran Sanjay Prabhakaran outlines the footprint and strategy of women’s health specialist…
Europe / Ethics in Artificial Intelligence: Better Prepare Now for New EU Regulation
With upcoming EU regulation poised to have a massive impact on ethical regulations around AI in Europe, Bayer Head…
USA / Navigating Increasingly Stormy Market Access Waters
Certara’s Ulrich Neumann examines some of the major US market access trends of the past few years, including…
Chris Martin – CEO, Co-Founder and Director, ADC Therapeutics
Dr Chris Martin, CEO and co-founder of Swiss-headquartered antibody-drug conjugate cancer company, ADC…
APAC / Novartis APAC Oncology Head & Singapore Country President Kevin Zou
Kevin Zou highlights Novartis Oncology’s footprint and priorities in the diverse Asia-Pacific region, the…
Michael Quirmbach – CEO & President, CordenPharma
The CEO & President of CDMO CordenPharma, Dr Michael Quirmbach, delves into the contract manufacturing…
Norway / Ahead of the Curve on Digitalisation
Many countries have struggled to adapt to the shift to remote working and digital communication brought about by…
China / New Year, New Round of Drug Price Cuts
Since China first announced its ground-breaking volume-based procurement (VBP) pilot program to reduce drug…
Vaccines / Population Health: Access & Antivax Challenges
Vaccines have been touted – and rightly so – as the most cost-effective health intervention after access to…
Laurent Massuyeau – CEO, iQone Healthcare, Switzerland
Laurent Massuyeau introduces Swiss biosimilar commercialisation specialist iQone healthcare, why it made sense to…
Philippe Hügli – CEO, hystrix medical
hystrix medical is an online contracting marketplace for medical devices and replenishing/repeat purchase products…
Saudi Arabia / SFDA CEO Sets Out Strategic Priorities
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug…
Sanofi / The "Tortoise" of the COVID-19 Vaccine Race?
Sanofi CEO Paul Hudson ignited a heated debate around vaccine nationalism earlier this year when he suggested that…
China / 2020’s Biggest Biotech IPO in Profile
RemeGen, a low-profile Chinese biotech company based in Yantai city in the coastal Shandong province, around nine…
Japan / Eisai Targeting Global Leadership in Neurology & Oncology Niches
Founded by Toyoji Naito in December 1941, in just under 80 years, Eisai has become a leading global biopharma…
Thomas D. Madden – CEO, Acuitas Therapeutics
Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer…
Global / 5 Trends for Life Science Companies to Watch in 2021
After a transformative 2020, Shawview Consulting’s Brendan Shaw looks into his crystal ball and makes five…
Saudi Arabia / 5 Pharma Companies to Know
Following on from our list of the overall top 10 companies in the Saudi Arabian pharma market, here PharmaBoardroom…
Henry Suárez – President, ARAPF, Dominican Republic
The Association of Representatives, Agents and Pharmaceutical Producers (ARAPF), represents 65 companies in the…
Cell & Gene Therapy / Curing the Incurable: A New Age for Pharmacovigilance
Bayer’s Michael Levy casts his eye over the implications of the advent of cell and gene therapies on…
Europe / 5 Rare Disease Start-Ups to Watch
With Rare Disease Day falling on 28 February, PharmaBoardroom dedicates this month to exploring the global rare…
Cell & Gene Therapy / Collaborative Spirit
One of the more intriguing aspects about the new wave of cell and gene therapies (CGT) coming onstream is that they…
Charles Stacey – President & CEO, Cerecin
Cerecin’s Charles Stacey outlines the company’s journey towards launching a Phase III trial for its lead asset…
